|
1
|
Lickiss JN: Approaching cancer pain
relief. Eur J Pain. 5(Suppl A): 5–14. 2001. View Article : Google Scholar
|
|
2
|
Tegeder I, Grösch S, Schmidtko A, Häussler
A, Schmidt H, Niederberger E, Scholich K and Geisslinger G: G
protein-independent G1 cell cycle block and apoptosis with morphine
in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer
Res. 63:1846–1852. 2003.PubMed/NCBI
|
|
3
|
Harimaya Y, Koizumi K, Andoh T, Nojima H,
Kuraishi Y and Saiki I: Potential ability of morphine to inhibit
the adhesion, invasion and metastasis of metastatic colon 26-L5
carcinoma cells. Cancer Lett. 187:121–127. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta K, Kshirsagar S, Chang L, Schwartz
R, Law PY, Yee D and Hebbel RP: Morphine stimulates angiogenesis by
activating proangiogenic and survival-promoting signaling and
promotes breast tumor growth. Cancer Res. 62:4491–4498.
2002.PubMed/NCBI
|
|
5
|
Farooqui M, Li Y, Rogers T, Poonawala T,
Griffin RJ, Song CW and Gupta K: COX-2 inhibitor celecoxib prevents
chronic morphine-induced promotion of angiogenesis, tumour growth,
metastasis and mortality, without compromising analgesia. Br J
Cancer. 97:1523–1531. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen C, Farooqui M and Gupta K: Morphine
stimulates vascular endothelial growth factor-like signaling in
mouse retinal endothelial cells. Curr Neurovasc Res. 3:171–180.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katoh Y and Katoh M: Comparative genomics
on DKK2 and DKK4 orthologs. Int J Mol Med. 16:477–481.
2005.PubMed/NCBI
|
|
8
|
Scott EL and Brann DW: Estrogen regulation
of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease.
Brain Res. 1514:63–74. 2013. View Article : Google Scholar :
|
|
9
|
Willert K and Jones KA: Wnt signaling: is
the party in the nucleus? Genes Dev. 20:1394–1404. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Forget MA, Turcotte S, Beauseigle D, et
al: The Wnt pathway regulator DKK1 is preferentially expressed in
hormone-resistant breast tumours and in some common cancer types.
Br J Cancer. 96:646–653. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamabuki T, Takano A, Hayama S, et al:
Dikkopf-1 as a novel serologic and prognostic biomarker for lung
and esophageal carcinomas. Cancer Res. 67:2517–2525. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Makino T, Yamasaki M, Takemasa I, et al:
Dickkopf-1 expression as a marker for predicting clinical outcome
in esophageal squamous cell carcinoma. Ann Surg Oncol.
16:2058–2064. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patil MA, Chua MS, Pan KH, et al: An
integrated data analysis approach to characterize genes highly
expressed in hepatocellular carcinoma. Oncogene. 24:3737–3747.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aguilera O, Fraga MF, Ballestar E, et al:
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1)
gene in human colorectal cancer. Oncogene. 25:4116–4121. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu B, Yang X, Xu Y, et al: Elevated
expression of DKK1 is associated with cytoplasmic/nuclear
beta-catenin accumulation and poor prognosis in hepatocellular
carcinomas. J Hepato. 50:948–957. 2009. View Article : Google Scholar
|
|
16
|
Lee N, Smolarz AJ, Olson S, et al: A
potential role for Dkk-1 in the pathogenesis of osteosarcoma
predicts novel diagnostic and treatment strategies. Br J Cancer.
97:1552–1559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weinstein JL, Katzenstein HM and Cohn SL:
Advances in the diagnosis and treatment of neuroblastoma.
Oncologist. 8:278–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ko YB, Kim BR, Yoon K, Choi EK, Seo SH,
Lee Y, Lee MA, Yang JB, Park MS and Rho SB: WIF1 can effectively
co-regulate pro-apoptotic activity through the combination with
DKK1. Cell Signal. 26:2562–2572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Widy-Tyszkiewicz E, Scheel-Krüger J and
Christensen AV: Spatial navigation learning in spontaneously
hypertensive, renal hypertensive and normotensive Wistar rats.
Behav Brain Res. 54:179–185. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kissin I: Scientometric assessment of
drugs for chronic pain, 1979–2013: rapid growth of publications,
paucity of successful drugs. J Pain Res. 7:505–514. 2014.
View Article : Google Scholar
|
|
22
|
Lazarczyk M, Matyja E and Lipkowski AW: A
comparative study of morphine stimulation and biphalin inhibition
of human glioblastoma T98G cell proliferation in vitro. Peptides.
31:1606–1612. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Z, Li S, Song W, Li X, Li Q, Zhang
Z, Han Y, Zhang X, Miao S, Du R and Wang L: Lysine-specific
demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis
via activation of the Wnt/β-catenin pathway by down-regulating
Dickkopf-1 (DKK1) [corrected]. PLoS One. 8:e700772013. View Article : Google Scholar
|
|
24
|
Li S, Qin X, Guo X, Cui A, He Y, Wei S,
Wang X and Shan B: Dickkopf-1 is oncogenic and involved in invasive
growth in non small cell lung cancer. PLoS One. 8:e849442013.
View Article : Google Scholar
|
|
25
|
Sawada G, Ueo H, Matsumura T, Uchi R,
Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T,
et al: CHD8 is an independent prognostic indicator that regulates
Wnt/β-catenin signaling and the cell cycle in gastric cancer. Oncol
Rep. 30:1137–1142. 2013.PubMed/NCBI
|
|
26
|
Hidaka Y, Mitomi H, Saito T, Takahashi M,
Lee SY, Matsumoto K, Yao T and Watanabe S: Alteration in the
Wnt/β-catenin signaling pathway in gastric neoplasias of fundic
gland (chief cell predominant) type. Hum Pathol. 44:2438–2448.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mo ML, Li MR, Chen Z, Liu XW, Sheng Q and
Zhou HM: Inhibition of the Wnt palmitoyltransferase porcupine
suppresses cell growth and downregulates the Wnt/β-catenin pathway
in gastric cancer. Oncol Lett. 5:1719–1723. 2013.PubMed/NCBI
|
|
28
|
Zeng X, Huang H, Tamai K, Zhang X, Harada
Y, Yokota C, Almeida K, Wang J, Doble B, Woodgett J, et al:
Initiation of Wnt signaling: control of Wnt coreceptor Lrp6
phosphorylation/activation via frizzled, dishevelled and axin
functions. Development. 135:367–375. 2008. View Article : Google Scholar
|
|
29
|
Ikeda S, Kishida S, Yamamoto H, Murai H,
Koyama S and Kikuchi A: Axin, a negative regulator of the Wnt
signaling pathway, forms a complex with GSK-3beta and beta-catenin
and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
EMBO J. 17:1371–1384. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aberle H, Bauer A, Stappert J, Kispert A
and Kemler R: beta-catenin is a target for the ubiquitin-proteosome
pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schleiermacher G, Janoueix-Lerosey I and
Delattre O: Recent insights into the biology of neuroblastoma. Int
J Cancer. 135:2249–2261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Péczely L, Ollmann T, László K, et al:
Effects of ventral pallidal D1 dopamine receptor activation on
memory consolidation in morris water maze test. Behav Brain Res.
274:211–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oliveira L, Graeff FG, Pereira SR,
Oliveira-Silva IF, Franco GC and Ribeiro AM: Correlations among
central serotonergic parameters and age-related emotional and
cognitive changes assessed through the elevated T-maze and the
Morris water maze. Age (Dordr). 32:187–196. 2010. View Article : Google Scholar
|
